Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired α2-antiplasmin deficiency associated with AL amyloidosis

Thrombosis and Haemostasis

Volumn 102, Issue 6, 2009, Pages 1285-1287

  Colucci, Giuseppe ^a   Alberio, Lorenzo ^a   Jahns, Maximilian ^a   Keller, Peter ^a   Steiner, Simon ^a   Rüsges Wolter, Ilka ^a   Lämmle, Bernhard ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THALIDOMIDE; TRANEXAMIC ACID;

ADULT; AMYLOIDOSIS; BLOOD EXAMINATION; BONE MARROW BIOPSY; CASE REPORT; CHRONIC DISEASE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; LETTER; MAMMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ALPHA-2-ANTIPLASMIN; AMYLOIDOSIS; ANTIFIBRINOLYTIC AGENTS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; MIDDLE AGED; TRANEXAMIC ACID;

EID: 72949099045     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-04-0248     Document Type: Letter

References (10)

1. Mumford AD, O'Donnell J, Gillmore JD, et al. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br J Haematol 2000; 110: 454-460.
2. Gamba G, Montani N, Anesi E, et al. Clotting alterations in primary systemic amyloidosis. Haematologica 2000; 85: 289-292.
3. Zangari M, Elice F, Fink L, et al. Hemostatic dysfunction in paraproteinemias and amyloidosis. Semin Thromb Hemost 2007; 33: 339-349.
4. Taylor FB, Jr., Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-1330.
5. Dalton SO, Johansen C, Mellemkjaer L, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a populationbased cohort study. Arch Intern Med 2003; 163: 59-64.
6. Meyer K, Williams EC. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis. Am J Med 1985; 79: 394-396.
7. Takahashi H, Koike T, Yoshida N, et al. Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma. Am J Hematol 1986; 23: 153-166.
8. Liebman HA, Carfagno MK, Weitz IC, et al. Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase. Am J Clin Pathol 1992; 98: 534-541.
9. Medved L, Nieuwenhuizen W. Molecular mechanisms of initiation of fibrinolysis by fibrin. Thromb Haemost 2003; 89: 409-419.
10. Takahashi T, Suzukawa M, Akiyama M,et al. Systemic AL amyloidosis with disseminated intravascular coagulation associated with hyperfibrinolysis. Int J Hematol 2008; 87: 371-374.